Literature DB >> 16005187

Fcepsilon RI control of Ras via inositol (1,4,5) trisphosphate 3-kinase and inositol tetrakisphosphate.

Alexander J Stokes1, Lori M N Shimoda, Jae Wook Lee, Cora Rillero, Young-Tae Chang, Helen Turner.   

Abstract

The inositol (1,4,5) trisphosphate 3-kinase (ITP3K) phosphorylates Ins (1,4,5) P3 to produce Ins (1,3,4,5) P4. The ITP3K substrate, InsP3, and its product, InsP4, both have the potential to regulate mast cell function. Here, we explore the effects of dominant inhibition of ITP3K upon secretory responses and Ras GTPase activation following antigenic cross-linking of the mast cell immunoreceptor, FcvarepsilonRI. Inhibition of ITP3K potentiates both calcium release from intracellular stores and calcium-dependent secretory responses in mast cells. Moreover, mast cells with dominantly inhibited ITP3K display constitutive activation of Ras and certain Ras effector pathways. We propose three mechanisms by which ITP3K inhibition could influence Ras activation. The protection of InsP3 that results from ITP3K inhibition may lead to enhanced activation of calcium-sensitive Ras-GAPs or -GRFs. Similarly, the deficit in InsP4 may change the behavior of the InsP4 receptor, the GAP1(IP4BP). Our data are inconsistent with calcium-sensitive Ras-GAP activation being the primary consequence of ITP3K inhibition in mast cells. Rather, we observe potentiation of Ras responses in mast cells transfected with dominant negative GAP1(IP4BP). Moreover, shRNA-mediated knockdown of GAP1(IP4BP) potentiates FcvarepsilonRI-mediated Ras activation, indicating that this InsP4-binding GAP protein may be used by the FcvarepsilonRI immunoreceptor to regulate Ras.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005187     DOI: 10.1016/j.cellsig.2005.06.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

Review 1.  Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate.

Authors:  Karsten Sauer; Michael P Cooke
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

2.  The high affinity IgE receptor Fc epsilonRI is expressed by human intestinal epithelial cells.

Authors:  Eva Untersmayr; Giovanna Bises; Philipp Starkl; Charles L Bevins; Otto Scheiner; George Boltz-Nitulescu; Fritz Wrba; Erika Jensen-Jarolim
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

Review 3.  Inositol trisphosphate 3-kinases: focus on immune and neuronal signaling.

Authors:  Michael J Schell
Journal:  Cell Mol Life Sci       Date:  2010-01-12       Impact factor: 9.261

4.  Phosphoinositide and inositol phosphate analysis in lymphocyte activation.

Authors:  Karsten Sauer; Yina Hsing Huang; Hongying Lin; Mark Sandberg; Georg W Mayr
Journal:  Curr Protoc Immunol       Date:  2009-11

Review 5.  Regulation of Hematopoietic Cell Development and Function Through Phosphoinositides.

Authors:  Mila Elich; Karsten Sauer
Journal:  Front Immunol       Date:  2018-05-04       Impact factor: 7.561

6.  "TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".

Authors:  Jaime S Horton; Takuya Shiraishi; Naghum Alfulaij; Andrea L Small-Howard; Helen C Turner; Tatsuki Kurokawa; Yasuo Mori; Alexander J Stokes
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

7.  ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.

Authors:  Jianbiao Li; Ying-Hui Zhu; Pinzhu Huang; Baozhu Zhang; Jian Sun; Xin-Yuan Guan
Journal:  Diagn Pathol       Date:  2015-08-07       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.